Efficacy of ABI-007 plus Gemcitabine or Simplified LV5FU2 as First-line Therapy in Patients with Metastatic Pancreatic Cancer.

Registry ID

EUCTR2013-001463-23

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

GERCOR

Start date

2013-08-30

Completion date

2018-09-13

Last update

2026-08-16

Conditions

• metastatic pancreatic cancer

Summary

Evaluation of Progression free survival

Locations

• , , France

View on source registry